Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry

Juan Esteban Gómez‐Mesa; Stephania Galindo-Coral; María Claudia Montes; Walter Alarco; José Luis Barisani; Antonio Magaña; Eduardo Perna; Alexander Romero; Mario Speranza; Iván González; Fernando Wyss

doi:10.5334/gh.925

January 1, 2021Global HeartOpen Access

Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The CARDIO COVID 19-20 Registry will characterize the in-hospital population diagnosed with COVID-19 in Latin America in order to identify risk factors for worsening of cardiovascular comorbidities or for the appearance of cardiovascular complications during hospitalization and during the 30-day follow up period.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gómez‐Mesa et al. (2021) studied this question.

synapsesocial.com/papers/69370be862ddbfd8f5fa637f https://doi.org/10.5334/gh.925

View Full Paper

Ask AI

Bookmark

Share

Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry

Ask about this paper

Abstract

Discussion

Cite This Study

Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading